Real-world effectiveness of persistent tralokinumab use on clinician and patient-reported outcomes in patients with atopic dermatitis in the CorEvitas atopic dermatitis registry

被引：0

作者：

Silverberg, Jonathan ^{[1
]}

Balu, Sanjeev ^{[2
]}

Choi, C. Jean ^{[3
]}

Li, Alvin ^{[3
]}

Pugach, Oksana ^{[3
]}

Schneider, Shannon ^{[2
]}

Simpson, Eric ^{[4
]}

机构：

[1] George Washington Sch Med & Hlth Sci, Washington, DC USA

[2] LEO Pharm Inc, Madison, NJ USA

[3] CorEvitas LLC, Waltham, MA USA

[4] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA

来源：

关键词：

atopic dermatitis; tralokinumab; IL-13; real-world data; effectiveness;

D O I：

10.1093/bjd/ljae266.088

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

714

引用

页数：2